Overview and Scope
Patient blood management is a patient-focused, evidence-based, and systematic approach to optimize care of patients, who might need a blood transfusion, by optimizing patients’ blood, minimizing surgical blood loss, and harnessing the patient-specific physiological reserve of anemia thereby reducing the need for allogeneic blood transfusions.
Sizing and Forecast
The patient blood management market size has grown strongly in recent years. It will grow from $13.83 billion in 2023 to $14.86 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing number of surgical procedures, government initiatives, increasing demand for bloodless surgery, rising availability of blood substitutes, rising demand for quality healthcare.
The patient blood management market size is expected to see strongly grown in the next few years. It will grow to $19.07 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to aging population, growing demand for blood, changing demographics, increasing focus on personalized medicine, growing demand for safe and effective blood transfusions, increasing healthcare spending. Major trends in the forecast period include patient-centered care, data-driven decision-making, hemoglobin optimization, collaborative care, expanded use of autologous blood.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
Segmentation & Regional Insights
The patient blood management market covered in this report is segmented –
1) By Product: Instruments, Accessories, Reagents And Kits, Softwares
2) By Component: Plasma, Whole Blood, Red Blood Cells
3) By Application: Hospital, Clinic, Other Applications
North America was the largest region in the patient blood management market in 2023. Western Europe was the second-largest region in the patient blood management market share. The regions covered in the patient blood management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3240&type=smp
Major Driver Impacting Market Growth
The rising number of accidents, trauma cases, and surgical procedures contributed to the growth of the global patient blood management market. According to WHO, 1.35 million people die every year due to road accidents, and low-income and middle-income countries account for 93% of the fatalities occurring in the world due to road accidents. According to the Centers for Disease Control and Prevention, in 2021, the cesarean birth rate was 32.1% of all births. Increased number of accidents, trauma cases, and surgical procedures resulted in increased demand for blood, and its products are driving the market.
Key Industry Players
Major companies operating in the patient blood management market include Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor Inc., B. Braun Melsungen AG, Macopharma, bioMérieux SA, Asahi Kasei Corporation, KANEKA CORPORATION, Bio-Rad Laboratories Inc, Abbott Laboratories, Grifols, Roche, LIVANOVA PLC, Danaher, Mediware information systems, Kawasumi Laboratories, Haier Biomedical, Diatron MI Zrt., BAG Diagnostics GmbH, Hitachi Ltd., Ortho Clinical Diagnostics, Beckman Coulter Inc., Siemens Healthineers, Thermo Fisher Scientific Inc., Sysmex Corporation, Nihon Kohden Corporation, Radiometer Medical ApS, Instrumentation Laboratory, F. Hoffmann-La Roche Ltd, Grifols Diagnostic Solutions Inc., HemoCue AB, Immucor GTI Diagnostics
The patient blood management market report table of contents includes:
1. Executive Summary
2. Patient Blood Management Market Characteristics
3. Patient Blood Management Market Trends And Strategies
4. Patient Blood Management Market - Macro Economic Scenario
5. Global Patient Blood Management Market Size and Growth
.
.
.
31. Global Patient Blood Management Market Competitive Benchmarking
32. Global Patient Blood Management Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Patient Blood Management Market
34. Patient Blood Management Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Patient Blood Management Market Research Report: By Product (Instruments, Accessories, Reagents and Kits, Software), By Component (Whole Blood, Plasma) and By End-User (Blood Banks, Hospitals, Diagnostic Clinics and & Pathology Labs)-Forecast to 2027Market Analysis The global patient blood management market is likely to touch USD 15,848 million at a 6.48% CAGR between 2019- 2025, as per the recent report by Market Research Future (MRFR).
Patient blood management is used for minimizing blood loss at the time of surgical operations and optimizing the blood of the patient.
This is carried out by doctors for patients that possess the risk of blood loss at the time of surgical intervention.
Some of its different types include software, reagents and kits, and instrument accessories.Various factors are adding to the global patient blood management market growth.
Regional Analysis Based on the region, the global patient blood management market report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA).
The growing prevalence of cancer, the increasing number of surgical procedures, the presence of a well-established healthcare sector, and the presence of several hospitals in the US are adding to the growth of the market in the region.
The Business Research Company published its Patient Blood Management Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Patient Blood Management market.
The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.The report covers the patient blood management market’s segments-1) By Product: Instruments, Accessories, Reagents And Kits, Software2) By Component: Plasma, Whole Blood, Red Blood Cells3) By Application: Hospital, Clinic, Others.View Complete Report: https://www.thebusinessresearchcompany.com/report/patient-blood-management-market-global-report-2020-30-covid-19-growth-and-changePatient Blood Management Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities.
The entire supply chain has been disrupted, impacting the market negatively.
The market is then expected to recover and reach $12.63 billion in 2023 at a CAGR of 8.28%.HEMAsavR is a sterile medical device to capture and transfer blood, which is increasingly being used to collect and salvage blood in surgical procedures and respond quickly to unanticipated blood loss.
